Kiniksa Pharmaceuticals International, plc SEC filings KNSA

Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.

Kiniksa Pharmaceuticals International, plc SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Nov 3, 2026 Nov 2, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
10-Q Quarterly report Oct 27, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
8-K Current report
Officer or director change
Oct 22, 2026 Oct 17, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Jul 15, 2026
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 4, 2026 Aug 1, 2026
4 Insider transaction Jul 31, 2026 Jul 29, 2026
144 Notice of proposed sale Jul 29, 2026 —
144 Notice of proposed sale Jul 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2026 —
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 28, 2026 Jul 28, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
3 Initial insider ownership Jul 6, 2026 Jun 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 29, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 26, 2026 —
8-K Current report
Material agreement
May 26, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
8-K Current report
Officer or director change
May 1, 2026 Apr 30, 2026
4 Insider transaction May 1, 2026 May 1, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 29, 2026 Apr 28, 2026
144 Notice of proposed sale Apr 28, 2026 —
10-Q Quarterly report Apr 28, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 28, 2026 Apr 28, 2026
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 May 19, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
144 Notice of proposed sale Apr 9, 2026 —
144 Notice of proposed sale Apr 9, 2026 —
4 Insider transaction Apr 8, 2026 Apr 7, 2026
4 Insider transaction Apr 8, 2026 Apr 7, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 7, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
4 Insider transaction Apr 8, 2026 Apr 7, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
144 Notice of proposed sale Apr 6, 2026 —
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 3, 2026 Jan 15, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Jan 15, 2026
4 Insider transaction Apr 3, 2026 Jan 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 11, 2026 Mar 9, 2026
144 Notice of proposed sale Mar 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2026 —
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
S-8 Employee stock plan registration Feb 24, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 1, 2026
8-K Current report
Officer or director change
Jan 14, 2026 Jan 10, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 9, 2026 Jan 8, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 14, 2025 Nov 12, 2025
4 Insider transaction Nov 14, 2025 Nov 12, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
144 Notice of proposed sale Oct 31, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
4 Insider transaction Oct 30, 2025 Oct 28, 2025
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
4 Insider transaction Oct 22, 2025 Oct 20, 2025
144 Notice of proposed sale Oct 20, 2025 —
144 Notice of proposed sale Oct 20, 2025 —
4 Insider transaction Oct 16, 2025 Oct 14, 2025
144 Notice of proposed sale Oct 14, 2025 —
4 Insider transaction Oct 8, 2025 Oct 4, 2025
4 Insider transaction Oct 1, 2025 Sep 29, 2025
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 17, 2025 Sep 15, 2025
144 Notice of proposed sale Sep 15, 2025 —
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 5, 2025 —
144 Notice of proposed sale Sep 4, 2025 —
144 Notice of proposed sale Sep 4, 2025 —
4 Insider transaction Sep 3, 2025 Sep 1, 2025
144 Notice of proposed sale Sep 3, 2025 —
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
144 Notice of proposed sale Sep 3, 2025 —
8-K Current report
Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
144 Notice of proposed sale Aug 14, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
4 Insider transaction Aug 8, 2025 Aug 6, 2025
4 Insider transaction Aug 7, 2025 Jul 15, 2025
144 Notice of proposed sale Aug 6, 2025 —
4 Insider transaction Aug 6, 2025 Aug 4, 2025
4 Insider transaction Aug 6, 2025 Jul 15, 2025
144 Notice of proposed sale Aug 5, 2025 —
144 Notice of proposed sale Aug 4, 2025 —
144 Notice of proposed sale Aug 4, 2025 —
4 Insider transaction Aug 1, 2025 Jul 30, 2025
144 Notice of proposed sale Jul 30, 2025 —
10-Q Quarterly report Jul 29, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jul 16, 2025 Jul 14, 2025
144 Notice of proposed sale Jul 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 9, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 11, 2025 —
144 Notice of proposed sale Jun 10, 2025 —
144 Notice of proposed sale Jun 9, 2025 —
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
8-K Current report
Regulation FD disclosure
Jun 5, 2025 Jun 5, 2025
144 Notice of proposed sale Jun 3, 2025 —
144 Notice of proposed sale Jun 3, 2025 —
144 Notice of proposed sale Jun 3, 2025 —
8-K Current report
Shareholder vote results
Jun 3, 2025 Jun 3, 2025
4 Insider transaction May 28, 2025 May 23, 2025
DEFA14A Additional proxy material May 28, 2025 —
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction May 21, 2025 May 19, 2025
144 Notice of proposed sale May 19, 2025 —
4 Insider transaction May 15, 2025 May 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
4 Insider transaction May 9, 2025 May 7, 2025
4 Insider transaction May 9, 2025 May 7, 2025
4 Insider transaction May 9, 2025 May 7, 2025
DEFA14A Additional proxy material May 9, 2025 —
144 Notice of proposed sale May 7, 2025 —
144 Notice of proposed sale May 7, 2025 —
144 Notice of proposed sale May 7, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KNSA (Nasdaq)
Fiscal year ends
December 31
Headquarters
London
SEC filer status
Large accelerated filer
SEC CIK
1730430
Former names
Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.